Paragon Biosciences

Venture Capital/Incubator

Paragon Biosciences is a dual venture capital firm and incubator that invests in biopharmaceutical startups developing therapeutics for diseases with unmet treatment needs.

Approach

Dual venture capital/incubator- Paragon is a dual venture capital firm and incubator that invests in pharmaceutical companies developing therapeutics for diseases with unmet treatment needs. Paragon provides simultaneous funding and strategic resources in order to accelerate the growth of the companies it invests in. The current portfolio includes companies in the following therapeutic areas: dermatology, sleep, cognitive disorders, CNS, immunology, and alzheimer’s. The pipelines of these companies are at various stages of development and include 1 drug that has completed phase III trials.

Portfolio

Launched:

Castle Creek Pharma-Rare genetic dermatology conditions

Harmony Biosciences-Rare sleep and cognitive disorders

Skyline Biosciences-Oncology

Emalex-CNS disorders

Incubating:

Decade Pharmaceuticals-Alzheimer’s

Immunogenic-immunology

Development Stage

NDA Submission: Narcolepsy

Phase II: Epidermolysis bullosa simplex, Pediatric Narcolepsy

Preclinical: Rare genetic dermatologic conditions, Vitiligo, Tourettes

Partnering

Paragon could be interested in partnering with technologies that are potential therapeutics for diseases with unmet treatment needs.

Contact Information   


Claim Your Page
Is this your organization? Submit your contact information below.